DANIEL
BLÁZQUEZ GAMERO
Profesor asociado de Ciencias de la Salud
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (64)
2024
-
Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak
mSphere, Vol. 9, Núm. 3
-
Congenital CMV Monthly International Virtual Clinics: A cCMVnet European Initiative
Pediatric Infectious Disease Journal
-
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)
The Lancet Regional Health - Europe, Vol. 40
-
Renal Function Impairment in Children With Congenital Cytomegalovirus Infection: A Cross-sectional Study
The Pediatric infectious disease journal, Vol. 43, Núm. 3, pp. 257-262
2023
-
Clinical outcomes and antibody transfer in a cohort of infants with in utero or perinatal exposure to SARS-CoV-2 (Coronascope Study)
European Journal of Pediatrics, Vol. 182, Núm. 10, pp. 4647-4654
-
Congenital cytomegalovirus infection: the state of the art and future perspectives
Frontiers in Pediatrics, Vol. 11
-
Discrepancies in Management of Congenital Cytomegalovirus in Preterm Infants: An International Survey
Pediatric Infectious Disease Journal, Vol. 42, Núm. 9, pp. 801-803
-
Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain
European Journal of Pediatrics, Vol. 182, Núm. 7, pp. 3057-3062
-
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine, Vol. 15, Núm. 1
-
Results of the REIV-TOXO national survey on prenatal screening for toxoplasmosis in Spain
Enfermedades Infecciosas y Microbiologia Clinica
-
Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial
The Lancet Infectious Diseases, Vol. 23, Núm. 12, pp. 1383-1394
-
The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission
PLoS ONE, Vol. 18, Núm. 2 February
2022
-
Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study
Thorax, Vol. 77, Núm. 10, pp. 1023-1029
-
Congenital cytomegalovirus infection in newborns born to HIV-infected mothers
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 10, pp. 557-561
-
Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2
Journal of Infection, Vol. 85, Núm. 1, pp. 86-89
-
Hand Hygiene Compliance Rates in 9 Pediatric Intensive Care Units Across Europe: Results from the Reducing Antimicrobial use and Nosocomial Infections in Kids Network
The Pediatric infectious disease journal, Vol. 41, Núm. 10, pp. e434-e437
-
Impact of the COVID-19 Pandemic on the Diagnosis of Congenital Cytomegalovirus Infection in Spain
Pediatric Infectious Disease Journal, Vol. 41, Núm. 7, pp. 590-592
-
Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population
Archives of Disease in Childhood, Vol. 107, Núm. 11, pp. 1051-1058
-
Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort
Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768
-
Rituximab as Second-Line Treatment in Anti-NMDAR Encephalitis after Herpes Simplex Encephalitis in Children
Indian Journal of Pediatrics